184
Participants
Start Date
March 31, 2004
Primary Completion Date
October 31, 2008
Study Completion Date
October 31, 2008
Deferasirox
Deferasirox available as 125 mg, 250 mg or 500 mg tablets
New York Presbyterian Hospital, New York
Stanford Hospital, Stanford
Children's Hospital and Research center at Oakland, Oakland
Childres's Hospital Boston, Boston
Children's Hospital of Philadelphia, Philadelphia
Novartis Investigative Site, Bruges
Novartis Investigative Site, Brussels
Novartis Investigative Site, Ghent
Novartis Investigative Site, La Louvière
Novartis Investigative Site, Leuven
Novartis Investigative Site, Montreal
Novartis Investigative Site, Toronto
Novartis Investigative Site, Créteil
Novartis Investigative Site, Le Kremlin-Bicêtre
Novartis Investigative Site, Lille
Novartis Investigative Site, Troyes
Novartis Investigative Site, Düsseldorf
Novartis Investigative Site, Hanover
Novartis Investigative Site, Ulm
Novartis Investigative Site, Bologna
Novartis Investigative Site, Brindisi
Novartis Investigative Site, Cagliari
Novartis Investigative Site, Genova
Novartis Investigative Site, Milan
Novartis Investigative Site, Pavia
Novartis Investigative Site, Rome
Novartis Investigative Site, Torino
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY